MDT vs. ESLOY: Which Stock Is the Better Value Option?

Core Viewpoint - Medtronic (MDT) is currently positioned as a more attractive investment option compared to EssilorLuxottica Unsponsored ADR (ESLOY) based on various valuation metrics and earnings outlook [3][7]. Valuation Metrics - MDT has a forward P/E ratio of 17.47, significantly lower than ESLOY's forward P/E of 38.76, indicating that MDT may be undervalued relative to ESLOY [5]. - The PEG ratio for MDT is 2.60, while ESLOY's PEG ratio stands at 3.87, suggesting that MDT offers better value when considering expected earnings growth [5]. - MDT's P/B ratio is 2.59, compared to ESLOY's P/B of 3.41, further supporting the notion that MDT is more favorably valued [6]. Earnings Outlook - MDT is currently enjoying an improving earnings outlook, which is reflected in its Zacks Rank of 2 (Buy), while ESLOY has a Zacks Rank of 4 (Sell) [3][7].